RESERVE PETROLEUM CO financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data RESERVE PETROLEUM CO files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue		6.31	8.33	6.63	4.08	9.12	16.2	12.5	15.1	16.7
Cost of revenue		2.19	2.39	2.33	1.88	2.72	3.64
Gross profit		4.12	5.94	4.29	2.2	6.39	12.5
General and administrative	1.58	1.62	1.68	1.72	1.8	1.96	2.12	2.61	3.08	2.66
Operating expenses	6.87	6.83	6.37
Operating income	-0.58	-0.52	1.96	-1.01	-3.16	0.66	6.43	-1.27	2.25	4.29
Interest expense							0.03	0.07	0.07	0.06
Interest income	0.05	0.13	0.35	0.52	0.15	0.02	0.1	0.44	0.2	0.01
Other non-operating income	0.3	0.68	0.83	0.6	0.78	0.69	-1.19	0.97	0.19	1.85
Pre-tax income	-0.26	0.1	2.7	-0.49	-2.49	1.2	5.05
Income tax	-0.17	-0.58	0.39	-0.22	-0.53	-0.05	1.07	-0.17	0.5	1.27
Income from continuing operations								-0.06	2.03	4.9
Net income to minority interests							-0.03
Net income	-0.08	0.69	2.31	-0.27	-1.96	1.25	4	-0.09	1.99	4.86
EBITDA	2.14	1.62	4.06	1.77	0.16	3.38	9.23	-1.2	2.27	4.29
EPS, basic	-0.53	4.35	14.69	-1.70	-12.49	8.00	25.62	-0.36	13.18	32.32
EPS, diluted	-0.53	4.35	14.69	-1.70	-12.49	8.00	25.62	-0.36	13.18	32.32
Shares, basic (weighted)	0.16	0.16	0.16	0.16	0.16	0.16	0.16	0.16	0.15	0.15
Shares, diluted (weighted)	0	0	0	0	0	0	0.16	0.16	0.15	0.15

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	8.07	4.77	6.43	2.74	16.2	10.1	7.3	5.22	3.92	2.05
Short-term investments	13.4	16.4	16.2	18.5	1.52		4.21
Receivables	0.76	0.83	0.85	0.97	0.79	1.36	2.32	2.37	2.77	2.99
Total current assets	23.3	23	24.2	22.9	21.5	21	16.2	12.8	9.44	9.84
Property, plant and equipment	10.9	10.6	11.2	9.51	7.48	7.56	14.9	17.6	21.3	26.5
Long-term investments			2.57	2.64	3.02	4.69	7.56	5.98	5.66	5.22
Other non-current assets				0.69	0.12	0.11
Total assets	36.9	36.3	38	35.7	32.1	33.2	38.7	36.4	36.4	41.6
Accounts payable	0.16	0.24	0.32	0.16	0.25	0.26	0.4	0.54	0.52	1.18
Total current liabilities	0.19	0.26	0.34	0.18	0.26	0.52	0.61	0.69	0.71	2.19
Long-term debt							1.3	1.16	1.01	0
Total liabilities	4.69	4.18	4.39	3.6	2.76	3.43	6.34	5.64	5.74	7.61
Paid-in capital	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07	0.07
Retained earnings	33.6	33.5	35	33.7	30.9	31.4	33.8	32.2	32.7	36.1
Treasury stock	-1.5	-1.53	-1.6	-1.69	-1.69	-1.75	-1.75	-1.82	-2.42	-2.47
Shareholders' equity	32.3	32.1	33.6	32.1	29.4	29.8	32.2	30.5	30.4	33.8
Minority interests							0.15	0.2	0.21	0.23
Total equity	32.3	32.1	33.6	32.1	29.4	29.8	32.4	30.7	30.6	34
Total liabilities and equity	36.9	36.3	38	35.7	32.1	33.2	38.7	36.4	36.4	41.6
Shares outstanding	0.16	0.16	0.16	0.16	0.16	0.16	0.16	0.16	0.15	0.15

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-0.08	0.69	2.31	-0.27	-1.96	1.25	3.97	-0.09	1.99	4.86
Depreciation and amortization	2.72	2.13	2.1	2.78	3.32	2.73	2.8	0.08	0.02	0
Deferred income tax	-0.12	-0.59	0.29	-0.29	-0.35	-0.02	1.07	-0.4	0.43	1.25
Change in receivables	-0.07	-0.1	0.03	-0.1	0.11	-0.36	-0.72	-0.25	0.08	-0.05
Change in payables	0.01	-0.01	0	0.01	0.05	0.01	0.22	0.38	0.29	0.2
Cash from operations	2.78	2.77	4.85	2.86	1.09	3.78	8.63	5.59	7.92	9.94
Purchases of investments			-32.7	-37.7	-8.08		-4.21	-7.69	-0.31	0
Sales and maturities of investments	17.3	29.8	32.8	35.4	25.1	1.52	0	9.68	2.53	0
Cash from investing	-7.63	-5.2	-2.16	-4.29	13.1	-9	-9.88	-5.99	-6.97	-10.2
Share buybacks	-0.09	-0.04	-0.06	-0.09	-0	-0.05	-0	-0.07	-0.6	-0.06
Dividends paid	-0.92	-0.84	-0.96	-1.48	-0.78	-0.78	-1.56	-1.56	-1.55	-1.52
Cash from financing	-1.01	-0.87	-1.02	-2.26	-0.79	-0.84	-1.58	-1.68	-2.24	-1.65
Net change in cash	-5.87	-3.3	1.66	-3.69	13.4	-6.06	-2.83	-2.08	-1.29	-1.87
Interest paid					0.02	0.02	0.03	0.06	0.05	0.04
Income taxes paid	0			0.16		0.09	0	0.43	-0.01	0.06

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $212.00 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	27.3%	Operating income / revenue.
Net margin	26.9%	Net income / revenue.
Operating cash flow margin	58.5%	Cash from operations / revenue.
Return on equity (ROE)	15.2%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	12.6%	Net income / average total assets.
Return on invested capital (ROIC)	13.3%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	10.3%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	1.1%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	32.5%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	90.4%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-12.6%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y	88.8%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-22.6%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	93.0%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	144.8%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	6.7%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y	145.2%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	8.1%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	25.5%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	4.8%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	55.7%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	10.9%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	1.6%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	2.8%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	14.4%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	2.4%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	5.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-1.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-1.0%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	10.1x	Current assets / current liabilities.
Quick ratio	5.70x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	2.68x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	16.6%	Total liabilities / total assets.
Interest coverage	87.1x	Operating income / interest expense.
Working capital	$9.8M	Current assets - current liabilities.
Tangible book value	$35.8M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.47x	Revenue / average total assets.
Fixed asset turnover	0.76x	Revenue / average property, plant and equipment.
Receivables turnover	6.23x	Revenue / average receivables.
Days sales outstanding	59 days	365 x average receivables / revenue.

Per share

Metric	Value	How it is calculated
EPS, diluted	$35.91	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$133.68	Revenue / diluted weighted shares.
Operating cash flow per share	$78.20	Cash from operations / diluted weighted shares.
Book value per share	$236.20	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$236.20	Tangible book value / shares outstanding.
Cash per share	$19.08	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$32.1M	Share price x shares outstanding.
Enterprise value	$29.2M	Market cap + total debt - cash - short-term investments.
P/E	5.90x	Market cap / net income. Only when net income is positive.
P/S	1.59x	Market cap / revenue.
P/B	0.90x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	0.90x	Market cap / tangible book value, when positive.
P/OCF	2.71x	Market cap / cash from operations, when positive.
EV/Sales	1.44x	Enterprise value / revenue.
EV/EBIT	5.29x	Enterprise value / operating income, when both are positive.
Earnings yield	16.9%	Net income / market cap (the inverse of P/E).
Shareholder yield	0.1%	(Dividends paid + share buybacks) / market cap.
PEG	0.73x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was RESERVE PETROLEUM CO's revenue in fiscal 2025?

RESERVE PETROLEUM CO reported revenue of $16.7M for fiscal 2025, 10.3% higher than the year before.

Was RESERVE PETROLEUM CO profitable in fiscal 2025?

Yes. Net income was $4.9M, a net margin of 29.1%.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to RESERVE PETROLEUM CO